Related references
Note: Only part of the references are listed.The effect of cilostazol, a phosphodiesterase 3 (PDE3) inhibitor, on human hair growth with the dual promoting mechanisms
Hye-In Choi et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2018)
Cilostazol protects mice against myocardium ischemic/reperfusion injury by activating a PPARγ/JAK2/STAT3 pathway
Jiangjin Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Effect of cilostazol in treating diabetes-associated microvascular complications
Nicole J. Asal et al.
ENDOCRINE (2017)
Induction of Angiogenesis by a Type III Phosphodiesterase Inhibitor, Cilostazol, Through Activation of Peroxisome Proliferator-Activated Receptor-γ and cAMP Pathways in Vascular Cells
Fumihiro Sanada et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Prognostic Value of Basic Fibroblast Growth Factor (bFGF) in Lung Cancer: A Systematic Review with Meta-Analysis
Mingming Hu et al.
PLOS ONE (2016)
Stimulation of angiogenesis by cilostazol accelerates fracture healing in mice
Steven C. Herath et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2015)
Role of Hydrogen Sulfide in Ischemia-Reperfusion Injury
Dongdong Wu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
Cilostazol induces vasodilation through the activation of Ca2+-activated K+ channels in aortic smooth muscle
Hongliang Li et al.
VASCULAR PHARMACOLOGY (2015)
Effects of ischemic preconditioning and cilostazol on muscle ischemia-reperfusion injury in rats
Carlos Alberto da Silva Frias Neto et al.
ACTA CIRURGICA BRASILEIRA (2014)
Time course change of COX2-PGI2/TXA2 following global cerebral ischemia reperfusion injury in rat hippocampus
Lijuan Yu et al.
BEHAVIORAL AND BRAIN FUNCTIONS (2014)
Cilostazol, a selective Type III phosphodiesterase inhibitor: prevention of cervical myelopathy in a rat chronic compression model Laboratory investigation
Shinji Yamamoto et al.
JOURNAL OF NEUROSURGERY-SPINE (2014)
Cilostazol Renoprotective Effect: Modulation of PPAR-γ, NGAL, KIM-1 and IL-18 Underlies Its Novel Effect in a Model of Ischemia-Reperfusion
Diaa Ragab et al.
PLOS ONE (2014)
Effect of cilostazol pretreatment on the PARP/AIF-mediated apoptotic pathway in rat cerebral ischemia-reperfusion models
Xiao-Hong Ba et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2014)
Aspirin and Probenecid Inhibit Organic Anion Transporter 3-Mediated Renal Uptake of Cilostazol and Probenecid Induces Metabolism of Cilostazol in the Rat
Chong Wang et al.
DRUG METABOLISM AND DISPOSITION (2014)
DNA Microarray and Quantitative Analysis Reveal Enhanced Myocardial VEGF Expression with Stunted Angiogenesis in Human Tetralogy of Fallot
Theodorus H. F. Peters et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2013)
Cilostazol promotes angiogenesis after peripheral ischemia through a VEGF-dependent mechanism
Federico Biscetti et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Cilostazol inhibits accumulation of triglycerides in a rat model of carotid artery ligation
Hiroki Tanaka et al.
JOURNAL OF VASCULAR SURGERY (2013)
A novel vasculo-angiogenic effect of cilostazol mediated by cross-talk between multiple signalling pathways including the ERK/p38 MAPK signalling transduction cascade
Ting-Hsing Chao et al.
CLINICAL SCIENCE (2012)
Simultaneous measurement of adenosine triphosphate release and aggregation potentiates human platelet aggregation responses for some subjects, including persons with Quebec platelet disorder
Catherine P. M. Hayward et al.
THROMBOSIS AND HAEMOSTASIS (2012)
HGF/c-Met signalling promotes Notch3 activation and human vascular smooth muscle cell osteogenic differentiation in vitro
Yiwen Liu et al.
ATHEROSCLEROSIS (2011)
Cilostazol and atherogenic dyslipidemia: a clinically relevant effect?
Manfredi Rizzo et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
Analysis of rpoS and bolA gene expression under various stress-induced environments in planktonic and biofilm phase using 2-ΔΔCT method
Mohd Adnan et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Ischemia and reperfusion-from mechanism to translation
Holger K. Eltzschig et al.
NATURE MEDICINE (2011)
Cilostazol, Not Aspirin, Reduces Ischemic Brain Injury via Endothelial Protection in Spontaneously Hypertensive Rats
Naoki Oyama et al.
STROKE (2011)
Relative spatial distributions of coronary artery bypass graft insertion and acute thrombosis: A model for protection from acute myocardial infarction
Cathy Jeon et al.
AMERICAN HEART JOURNAL (2010)
Inhibition of endoplasm reticulum stress by ghrelin protects against ischemia/reperfusion injury in rat heart
Gai-Gai Zhang et al.
PEPTIDES (2009)
Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study
Yining Huang et al.
LANCET NEUROLOGY (2008)
Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury
Elizabeth Murphy et al.
PHYSIOLOGICAL REVIEWS (2008)
Distinct roles of autophagy in the heart during ischemia and reperfusion - Roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy
Yutaka Matsui et al.
CIRCULATION RESEARCH (2007)
PDGF gene therapy enhances expression of VEGF and bFGF genes and activates the NF-kappa B gene in signal pathways in ischemic flaps
XT Wang et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2006)
Intraoperative angiography leads to graft revision in coronary artery bypass surgery
PK Hol et al.
ANNALS OF THORACIC SURGERY (2004)
Homocysteine and risk of ischemic heart disease and stroke -: A meta-analysis
R Clarke et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Inhibition of platelet aggregation and the release of P-selectin from platelets by cilostazol
H Kariyazono et al.
THROMBOSIS RESEARCH (2001)
Share Paper
